Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea.
Condition: Diarrhea Interventions: Drug: DWJ1230; Drug: DWB2001 Sponsor: Daewoong Pharmaceutical Co. LTD. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Irritable Bowel Syndrome | Research